Skip to content

"Based on 'salivary biomarkers-tongue coating microecology-tongue image mapping spleen transformation function' to construct an intelligent early warning model for Type 2 Diabetes."

"Based on 'salivary biomarkers-tongue coating microecology-tongue image mapping spleen transformation function' to construct an intelligent early warning model for Type 2 Diabetes."

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001364
Enrollment
Unknown
Registered
2025-07-09
Start date
2024-06-20
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Sponsors

No. 16 Airport Road Guangzhou University of Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Healthy individuals obese individuals individuals with impaired glucose tolerance and patients with Type 2 Diabetes Mellitus. 2.Ages between 18 and 80 years old. 3.Participants are informed and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Type 1 Diabetes Mellitus 2.Patients with severe primary diseases of the liver kidneys cardiovascular system hematopoietic system endocrine system etc. (those whose severity prevents them from completing the trial) 3.Progressive difficulty swallowing and swallowing pain persistent vomiting unintentional weight loss 4.Those taking medications such as glucocorticoids that significantly affect blood sugar levels 5.Those who have taken drugs affecting salivary secretion within the last 2 weeks (e.g. anticholinergics and anticholinesterase drugs) 6.Patients with mental illnesses who lack insight and cannot express themselves accurately 7.Pregnant and lactating women 8.Those who have recently or are currently participating in other drug clinical trials or taking medications that may affect the assessment of the trial drug's efficacy (those who have taken antibiotics within 1 month) 9.Suspected or confirmed history of alcohol or drug abuse 10.Those whom the investigator deems unsuitable for participation in the clinical trial based on the investigator's judgment including other conditions that may reduce the likelihood of enrollment or complicate it such as frequently changing work environments that may lead to loss to follow-up

Design outcomes

Primary

MeasureTime frame
Blood Glucose;Blood Lipids;tongue image;

Countries

China

Contacts

Public ContactXiuying Kuang

No. 16 Airport Road Guangzhou University of Chinese Medicine First Affiliated Hospital

781037821@qq.com13728060088

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026